Please see Important Safety Information in pinned post and full Prescribing Information, including BOXED WARNING, at PADCEVpi.com.
To report SUSPECTED ADVERSE REACTIONS, contact Astellas Pharma US, Inc. at 1-800-727-7003 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
© 2024 Astellas Pharma Inc. or its affiliates and Pfizer Inc. All rights reserved.
MAT-US-PAD-2024-00459 10/24
All trademarks are the property of their respective owners.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://PADCEVhcp.com
- Keywords
- Atlanta.
Padcev® (Enfortumab Vedotin-Ejfv) Hcp Questions
Padcev® (Enfortumab Vedotin-Ejfv) Hcp's website is http://PADCEVhcp.com
Padcev® (Enfortumab Vedotin-Ejfv) Hcp's LinkedIn profile is https://www.linkedin.com/company/padcev-hcp
Padcev® (Enfortumab Vedotin-Ejfv) Hcp's industry is
Pharmaceutical Manufacturing
Padcev® (Enfortumab Vedotin-Ejfv) Hcp's top competitors are
Pfizer,
Keycity Capital,
Pioneer Diagnostic Center,
Centre For Snakebite Research & Interventions,
Palm Beach Children's Hospital,
Ferraro Law,
Cste Foundation,
Wsi,
Iccs Women In Cytometry,
Astellas Pharma.
Padcev® (Enfortumab Vedotin-Ejfv) Hcp's categories are Pharmaceutical Manufacturing
